Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Wentworth Kerry Create: Alert

All | News | Filings
Date FiledTypeDescription
03/02/2023 4 Wentworth Kerry (Chief Regulatory Officer) has filed a Form 4 on Nuvation Bio Inc.
Txns: Granted 400,000 options to buy @ $1.94, valued at $776k
08/31/2022 4 Wentworth Kerry (Chief Regulatory Officer) has filed a Form 4 on Nuvation Bio Inc.
Txns: Granted 252,000 options to buy @ $2.93, valued at $738.4k
05/25/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/19/2021 4 Wentworth Kerry (Chief Regulatory Officer) has filed a Form 4 on Flexion Therapeutics Inc
Txns: Disposed/sold 140,843 shares @ $8.5, valued at $1.2M
Disposed/sold 6,000 shares @ $8.5, valued at $51k
Disposed/sold 24,000 options to buy @ $19.61, valued at $470.6k
Disposed/sold 10,000 options to buy @ $22.91, valued at $229.1k
Disposed/sold 10,000 options to buy @ $18.16, valued at $181.6k
Disposed/sold 20,000 options to buy @ $18.2, valued at $364k
Disposed/sold 35,000 options to buy @ $18.56, valued at $649.6k
Disposed/sold 33,333 options to buy @ $22.31, valued at $743.7k
Disposed/sold 18,000 options to buy @ $14.75, valued at $265.5k
Disposed/sold 15,500 options to buy @ $15.78, valued at $244.6k
Disposed/sold 20,000 options to buy @ $11.41, valued at $228.2k
07/20/2021 4 Wentworth Kerry (Chief Regulatory Officer) has filed a Form 4 on Flexion Therapeutics Inc
Txns: Sold 3,944 shares @ $6.45, valued at $25.4k
06/28/2021 4 Wentworth Kerry (Chief Regulatory Officer) has filed a Form 4 on Flexion Therapeutics Inc
Txns: Granted 539 shares @ $7.78, valued at $4.2k
03/03/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/07/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/20/2020 4 Wentworth Kerry (Chief Regulatory Officer) has filed a Form 4 on Flexion Therapeutics Inc
Txns: Granted 38,750 shares @ $0
06/24/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/03/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/07/2020 4 Wentworth Kerry (Chief Regulatory Officer) has filed a Form 4 on Flexion Therapeutics Inc
Txns: Sold 3,724 shares @ $0
10/08/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/24/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/05/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/04/2019 4 Wentworth Kerry (Chief Regulatory Officer) has filed a Form 4 on Flexion Therapeutics Inc
Txns: Sold 622 shares @ $12.36, valued at $7.7k
10/09/2018 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/22/2018 4 Wentworth Kerry (Chief Regulatory Officer) has filed a Form 4 on Flexion Therapeutics Inc
Txns: Acquired 171 shares @ $21.22, valued at $3.6k
02/02/2018 4 Wentworth Kerry (Chief Regulatory Officer) has filed a Form 4 on Flexion Therapeutics Inc
Txns: Granted 8,333 shares @ $0
Granted 33,333 options to buy @ $22.31, valued at $743.7k
02/28/2014 4 Form 4 - Statement of changes in beneficial ownership of securities
02/19/2014 4 Wentworth Kerry (VP, CLinical, Reg, & Quality) has filed a Form 4 on AGENUS INC
Txns: Granted 130,000 options to buy @ $3, valued at $390k
09/13/2013 4 Wentworth Kerry (VP, Clinical, Reg, & Quality) has filed a Form 4 on AGENUS INC
Txns: Granted 40,000 options to buy @ $2.72, valued at $108.8k
06/17/2013 4 Wentworth Kerry (VP, Clinicial, Reg, & Quality) has filed a Form 4 on AGENUS INC
Txns: Granted 47,500 options to buy @ $3.61, valued at $171.5k
01/29/2013 4 Wentworth Kerry (VP, Clin, Reg & Quality) has filed a Form 4 on AGENUS INC
Txns: Granted 694 shares @ $4.35, valued at $3k
10/29/2012 4 Form 4 - Statement of changes in beneficial ownership of securities
09/14/2012 4 Wentworth Kerry (VP Clinical, Reg & Quality) has filed a Form 4 on AGENUS INC
Txns: Granted 5,044 shares @ $0
Unknown transaction of 1,034 restricted stock units @ $0
07/30/2012 4 Wentworth Kerry (VP, Clinical, Req & Quality) has filed a Form 4 on AGENUS INC
Txns: Granted 694 shares @ $4.61, valued at $3.2k
06/21/2012 4 Wentworth Kerry (VP, Clinical, Reg, & Quality) has filed a Form 4 on AGENUS INC
Txns: Granted 14,153 shares @ $5.26, valued at $74.4k
Disposed/sold 14,151 shares @ $4.99, valued at $70.6k
Disposed/sold 14,784 shares @ $5.05, valued at $74.7k
06/18/2012 4 Wentworth Kerry (VP, Clinical, Reg, & Quality) has filed a Form 4 on AGENUS INC
Txns: Granted 75,000 options to buy @ $5.34, valued at $400.5k
Granted 25,000 restricted stock units @ $0
04/30/2012 4 Wentworth Kerry (VP, Clinical, Reg, & Quality) has filed a Form 4 on AGENUS INC
Txns: Granted 695 shares @ $6.43, valued at $4.5k
03/16/2012 4 Wentworth Kerry (VP, Clinical, Reg, & Quality) has filed a Form 4 on AGENUS INC
Txns: Granted 6,077 shares @ $5.31, valued at $32.3k
01/31/2012 4 Wentworth Kerry (VP, Clinical, Reg, & Quality) has filed a Form 4 on AGENUS INC
Txns: Granted 694 shares @ $2.76, valued at $1.9k
01/05/2012 4 Wentworth Kerry (VP, Clinical, Reg, & Quality) has filed a Form 4 on AGENUS INC
Txns: Granted 22,121 shares @ $2.17, valued at $48k
12/29/2011 4 Wentworth Kerry (VP, Clinical, Reg, & Quality) has filed a Form 4 on AGENUS INC
Txns: Sold 3,156 shares @ $2.14, valued at $6.8k
Sold 1,893 shares @ $2.09, valued at $4k
Sold 8,939 shares @ $2.01, valued at $18k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy